SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-audited financial results for the quarter ended June 30, 2022 along with the Limited Review Report thereon will be considered and approved on Friday, August 12, 2022 at the corporate office of the Company.